Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Reexamination Certificate
2007-10-09
2007-10-09
Nguyen, Dave Trong (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
C424S130100, C424S164100, C530S350000, C530S387100, C435S007330
Reexamination Certificate
active
08471285
ABSTRACT:
The invention describes the identification, making, and isolation of immunoglobulin and antigen useful for preventing, diagnosing, and treating staphylococcal infections. The invention further describes an in vivo animal model useful for testing the efficacy of pharmaceutical compositions, including pharmaceutical compositions of immunoglobulin and isolated antigen.
REFERENCES:
patent: 4027010 (1977-05-01), Kiselev et al.
patent: 4197290 (1980-04-01), Yoshida
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4460575 (1984-07-01), d'Hinterland et al.
patent: 4482483 (1984-11-01), Curry et al.
patent: 4719290 (1988-01-01), Curry et al.
patent: 4732757 (1988-03-01), Stolle et al.
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4902616 (1990-02-01), Fournier et al.
patent: 5034515 (1991-07-01), Proctor
patent: 5055455 (1991-10-01), Pier
patent: 5153312 (1992-10-01), Porro
patent: 5175096 (1992-12-01), Höök et al.
patent: 5354654 (1994-10-01), Ligler et al.
patent: 5440014 (1995-08-01), Höök et al.
patent: 5505945 (1996-04-01), Gristina et al.
patent: 5530102 (1996-06-01), Gristina et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5545721 (1996-08-01), Carroll et al.
patent: 5571511 (1996-11-01), Fischer
patent: 5624904 (1997-04-01), Krieger et al.
patent: 5652217 (1997-07-01), Höök et al.
patent: 5770208 (1998-06-01), Fattom et al.
patent: 5840846 (1998-11-01), Höök et al.
patent: 5851535 (1998-12-01), Jolivet-Reynaud
patent: 5955074 (1999-09-01), Fischer
patent: 5955078 (1999-09-01), Burnham et al.
patent: 0724016 (1996-07-01), None
patent: 90/03398 (1990-04-01), None
patent: 93/09811 (1993-05-01), None
patent: WO93/09811 (1993-05-01), None
patent: WO93/19373 (1993-09-01), None
Plaunt et al, J Clin. Microbiology, May 1991, pp. 857-861, vol. 29(5).
Etzioni , A et al, ACTA Padiatr Scand 79, pp. 156-161, 1990.
Fattom, A et al, Infect. & Immnun., Jul. 1990, pp. 2367-2374, vol. 58(7).
Smith , D. G. E.et al, Infect. & Immun., Feb. 1991, pp. 617-624, vol. 59(2).
Van Bronswijk et al, Immunology, 1989, vol. 67, pp. 81-86.
Boslego, J.W. et al, Pergamon Press 1991, p. 211-223, In:Vaccine & Immuno-Therapy.
Ichiman et al, J. Applied Bacteriology, 1987, vol. 63,pp. 165-169.
Yoshida, K et al, Journal of Canadian Microbiology, vol. 34, 1988, pp. 913-915.
Yang et al, The Journal of Infectious Diseases, vol. 159(4) Apr. 1989.
Yoshida, K et al, Journal of Applied Bacteriology, 1988, vol. 65, pp. 491-499.
BIO, Oct. 17, 1994, Critical Synergy: The Biotechnology Industry and Intellectual Property Protection, p. 101.
Journal of Medical Microbiology, vol. 35, pp. 65-71, Oxford, U K.
Timmerman et al. Infect. & Immunity, Nov. 1991, vol. 59(11), pp. 4187-4192.
Modun ,B et al, Infection and Immunity, Sep. 1994, pp. 3850-3858, vol. 62(9).
Modun, B et al, Infection and Immunity, Jun. 1992, pp. 2551-2553, vol. 60(6).
Wilcox, M.H. et al, Journal of General Microbiology, 1991, pp. 2561-2570.
Timmerman et al, J. Med. Microbiol., vol. 35, 1991, pp. 65-71.
Fischer, 1988, Ped. Clinics of North Am. 35:517-533.
Ichiman et al, Journal of Applied Bacteriology, vol. 63, pp. 165-169, 1987.
Yoshida et al, Canadian Journal of Microbiology, vol. 34,pp. 913-915, 1988.
van Bronswijk et al, Immunology, 1989, vol. 67, pp. 81-86, 1989.
Baker et al, May, Pediatric Research, vol. 25(6 part 2), p. 275A, 1989.
Fischer, Pediatric Clinics of North America, vol. 35(3), Jun. pp. 517-533, 1988.
Wedren, Scand. J. Urol., Suppl, vol. 123, pp. 1-36, 1989.
Verhoef, J et al, Scand. J. Infect. Dis., Suppl. 41, pp. 56-63, 1983.
Fleer et al, Pediatric Infectious Disease, vol. 2(6), pp. 426-431, 1983.
Thorig et al, Infection, vol. 8(6), pp. 267-274, 1980.
Clark et al, Journal of Clinical Pathology, vol. 39, pp. 856-860, 1986.
Espersen, et al, ACTA Pathology Microbiol. Scand., Aug. 1981, vol. 89(4), pp. 253-260.
Clark et al, J. Clin Path. , vol. 39, pp. 856-860, 1986.
Fischer, G.W., New Topics in Pediatric Infectious Disease, vol. 35(3), Jun. 1988.
Ichiman, Y et al, J. Applied Bacteriology, vol. 63, pp. 165-169, 1987.
Baker, C,.J. et al, Pediatric Res. vol. 25(6 part 2), p. 275A (abstact), 1989.
Haque, K N, et al, AJDC, vol. 142, Dec., pp. 1293-1296, 1988.
Yamada, T et al, J. Clin. Microbiology, Oct. 1988, vol. 26(10), pp. 2167-2172.
Kojima, Y et al, J. Infectious Disease, vol. 162, pates 435-441, 1990.
Lamperi, S. et al, Biomat. Art. Cells, Art. Org., vol. 15(1), pp. 151-159, 1987.
Fleer, A et al, J. Infectious Disease, vol. 152(5), Nov. , pp. 930-937, 1985.
Ahmed, A et al, J. Applied Bacteriology, vol. 69, pp. 676-685, 1990.
Yang, K.D. et al, J. Infectious Diseases, vol. 159(4), pp. 701-707, Apr. 1989.
Espersen, F et al, J. Clinical Microbiology, Feb. 1986, vol. 23(2), pp. 339-342.
Espersen, F et al, ACTA Pathol. Microbiol. Scand. (Denmark), Aug. 1981, vol. 89(4), pp. 253-260.
Yoshida, K et al, Can. J. Microbiology, vol. 34, pp. 913-915, 1988.
Etzioni, A et al, ACTA Paediatr. Scand. vol. 79, p. 156-161, 1986.
Ichiman et al., “Relation of Human Serum Antibody AgainstStaphylococcus epidermidisCell Surface Polysaccharide Detected by Enzyme-linked Immunosorbent Assay to Passive Protection in the Mouse,”J. Appl. Bacteriol., 71:176-181 (1991).
Ichiman et al., “Monoclonal IgM Antibody Protection in Mice Against Infection with an Encapsulated Strain ofStaphylococcus epidermidis,” Can. J. Microbiol., 37:404-407 (1991).
Fischer et al., “Directed Immune Globulin Enhances Survival in an Intralipid Induced Neonatal Model of LethalStaphylococcus epidermidisSepsis,”Pediatr. Res., Abstract No. 1670, p. 281A (Apr. 1991).
C.C. Patrick, “Coagulase-negative Staphylococci: Pathogens with Increasing Clinical Significance,”J. of Pediatr., 116:497-507 (1990).
Freeman et al., “Association of Intravenous Lipid Emulsion and Coagulase-negative Staphylococcal Bacteremia in Neonatal Intensive Care Units,”New. Engl. J. Med., 323:301-308 (1990).
J. O. Klein, “From Harmless Commensal to Invasive Pathogen: Coagulase-Negative Staphylococci,”New Engl. J. Med., 323:339-340 (1990).
T. Niizuma, “Passive Protective Activities of Specific Human Immuno-globulin Against Strain ST67P ofStaphylococcus hyicusExtracted from Pooled Human Sera,”Chem. Abstracts, 115:181022v, p. 713 (1990).
T. Niizuma, “Passive Protection Activities of Specific Human Immunoglobulin Against Strain ST67P ofStaphylococcus hyicusExtracted from Pooled Human Sera,”St. Marianna Med. J., 18:940-946 (1990).
Certified English translation of document No. 10.
Espersen et al., “Solid Phase Radioimmunoassay for IgG Antibodies toStaphylococcus epidermis: Use in Serious Coagulase-negative Staphylococcal Infections,”Arch. Intern. Med., 147:689-693 (1987).
Ichiman et al., “Protective Antobodies in Human Sera Against Encapsulated Strains ofStaphylococcus epidermidis,” J. Appl. Bacteriol., 63:165-169 (1987).
Clark et. Al., “Opsonic Activity of Intravenous Immunoglobulin Preparations AgainstStaphylococcus epidermidis,” J. Clin. Pathol., 39:856-860 (1986).
Clark et al., “Opsonic Requirements ofStaphylococcus epidermidis,” J. Med. Microbiol., 22:1-7 (1986).
Fleer et al., “Opsonic Defense toStaphylococcus epidermidisin the Premature Neonate,”J. Infect. Dis., 152:930-937 (1985).
Fleer et al., “Septicemia due to Coagulase-negative Staphylococci in a Neonatal Intensive Care Unit: Clinical and Bacteriological Features and Contaminated Parenteral Fluids as a Source of Sepsis,”Pediatr. Infect. Dis., 2:426-431 (1983).
Fischer et al., “Diminished Bacterial Defenses with Intralipid,”The Lancet, 2:819-820 (1980).
Yoshida et al., “Immunological Response to a Strain ofStaphylococcus epidermidisin the Rabbit: Production of Protective Antibody,”J. Med. Microbiol., 11:371-377 (1977).
Yoshida et al., “Mouse Virulent Strain ofStaphylococcus epidermidis,” Jap. J. Microbiol., 20:209-217 (1976).
West et a
Henry M. Jackson Foundation for the Advancement of Military Medi
Lahive & Cockfield LLP
Mandragouras Esq. Amy E.
Nguyen Dave Trong
Portner Ginny Allen
LandOfFree
Isolated broadly reactive opsonic immunoglobulin for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated broadly reactive opsonic immunoglobulin for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated broadly reactive opsonic immunoglobulin for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870604